# Effect of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy

> **NCT06778460** · NA · RECRUITING · sponsor: **West China Hospital** · enrollment: 304 (estimated)

## Conditions studied

- Postoperative Chronic Pain

## Interventions

- **DRUG:** Esketamine-lidocaine group
- **OTHER:** Placebo group

## Key facts

- **NCT ID:** NCT06778460
- **Lead sponsor:** West China Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-05-05
- **Primary completion:** 2027-03-31
- **Final completion:** 2027-03-31
- **Target enrollment:** 304 (ESTIMATED)
- **Last updated:** 2025-01-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06778460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06778460, "Effect of Esketamine and Lidocaine on Postoperative Chronic Pain and Long-term Survival in Patients Undergoing Hepatectomy". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06778460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*